MEBO Moist Burn Ointment Combined with Zinc Oxide Ointment Can Also Treat Skin Damage Caused by Radiotherapy and Chemotherapy

Earlier, I wrote an article introducing the experience a patient's family member had in treating pressure sores and skin ulceration. That article was titled "Experience in Treating Pressure Sores and Skin Ulcers Shared by a Patient's Family Member." That family member used MEBO Moist Burn Ointment combined with zinc oxide ointment to treat skin ulceration and pressure sores.

After that article was published, a patient with both breast cancer and lymphoma, who was suffering severely from the aftereffects of radiotherapy and had serious skin damage, wanted to try it. I personally thought it feasible and suggested she give it a try. The result: in just two days of use, the patient's damaged skin improved dramatically.

This patient is an editor at a publishing house in Beijing. She had previously been treated at a tertiary Grade-A hospital in Beijing. After the radiotherapy aftereffects appeared, the hospital gave her some conventional ointments for skin damage, but the effect was poor and they were quite irritating to the skin. Switching to MEBO Moist Burn Ointment plus zinc oxide ointment, the experience was much better, and crucially, the damaged skin improved rapidly.

Afterward, I also recommended this regimen to another patient with skin damage after chemotherapy, and the result was also very good. This shows that this regimen is effective not only for ordinary pressure sores and skin ulcers but also has some effect on skin ulcers and damage caused by radiotherapy and chemotherapy. I hope fellow patients troubled by this problem will give it a try.

In addition, inspired by this medication experience, I believe that combining oral trace-element zinc preparations with an oral decoction made from the main ingredients of MEBO Moist Burn Ointment might also treat the internal-medicine aftereffects of radiotherapy, such as radiation pneumonitis, radiation esophagitis, and radiation enteritis. It could also be tried for various ulcerative diseases caused by chemotherapy.

In the future, when I have the opportunity, I will try this medication idea on certain patients with post-radiochemotherapy aftereffects; if the effect is good, I will promote it to readers.

Here I thank that patient's family member once again. Much of humanity's experience in treating disease has indeed been discovered by patients themselves through trial; such practical therapeutic experience is extremely valuable. This kind of real-world medication experience is far more effective than the treatment regimens listed in textbooks.